Oncology Convergence Revenue and Competitors
Estimated Revenue & Valuation
- Oncology Convergence's estimated annual revenue is currently $8.6M per year.
- Oncology Convergence's estimated revenue per employee is $216,000
Employee Data
- Oncology Convergence has 40 Employees.
- Oncology Convergence grew their employee count by 3% last year.
Oncology Convergence's People
Name | Title | Email/Phone |
---|---|---|
1 | President/Owner | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | VP Operations | Reveal Email/Phone |
4 | Director Client Services | Reveal Email/Phone |
5 | Accounts Payable/Accounts Receivable Manager | Reveal Email/Phone |
6 | President | Reveal Email/Phone |
7 | Coding Supervisor | Reveal Email/Phone |
8 | AR Specialist | Reveal Email/Phone |
9 | Financial Counselor | Reveal Email/Phone |
Oncology Convergence Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $359.5M | 951 | 11% | N/A | N/A |
#2 | $12.6M | 52 | 21% | N/A | N/A |
#3 | $7.8M | 36 | 0% | N/A | N/A |
#4 | $106.3M | 315 | 5% | N/A | N/A |
#5 | $137M | 406 | 17% | N/A | N/A |
#6 | $1881.3M | 4977 | 1105% | N/A | N/A |
#7 | $6.9M | 32 | 3% | N/A | N/A |
#8 | $6.9M | 32 | 3% | N/A | N/A |
#9 | $7.8M | 36 | 0% | N/A | N/A |
#10 | $14.1M | 58 | 9% | N/A | N/A |
What Is Oncology Convergence?
Oncology Convergence, Inc. (OCI) combines their operational, revenue cycle, and strategic expertise to assist hospitals and health systems grow, build, and maintain their oncology service lines. OCI's expertise allows us to provide a turn-key solution which helps ensure the success of the oncology service line.
keywords:N/AN/A
Total Funding
40
Number of Employees
$8.6M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8M | 40 | 0% | N/A |
#2 | $5.6M | 40 | 8% | N/A |
#3 | $4.6M | 40 | N/A | N/A |
#4 | $10.6M | 41 | 5% | N/A |
#5 | $35M | 41 | -2% | N/A |